A very positive outcome from the CSL112 trial PLUS a reduction in interest rates late next year might get CSL to $400. To be safe I wouldn't bet on much more than earnings growth equivalent movement in the share price. So, from here maybe circa $300 to $350 late next year which is roughly 30 to 35 times FY24 consensus. $400 a share are we're back to PEs at 40 which seems a stretch with rates still possible 3%+ late next year, so obviously will need some blockbuster CSL112 projections built into the price to get there.
A very positive outcome from the CSL112 trial PLUS a reduction...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$309.52 |
Change
1.420(0.46%) |
Mkt cap ! $149.5B | |||
| Open | High | Low | Value | Volume |
| $307.00 | $309.75 | $306.70 | $145.9M | 481.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 796 | $309.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $309.53 | 304 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |